跳至主要内容
临床试验/NCT04710069
NCT04710069已完成不适用

Randomized Controlled Trial for Postoperative opt-in Narcotic Treatment in Outpatient Endocrine Surgery

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2020年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
102
试验地点
2
主要终点
oral morphine equivalents consumed

研究概览

简要总结

pills go unused, generating waste and leaving an opportunity for misuse and abuse.

In a recent study, researchers let patients choose what medications to go home with after surgery. After their thyroid or parathyroid surgery, 96% of patients declined narcotic pain medication. They preferred to manage their pain with acetaminophen instead. Giving patients counseling and empowering them to choose significantly reduces the amount of opioids prescribed and wasted.

The aim of our study is to compare a similar "opt-in" protocol for narcotics to usual care (where patients are routinely discharged with opioids). We would elaborate upon the aforementioned study by studying patient pain scores on a more granular level once they return home.

Our study will be designed as a randomized, controlled trial. When adult patients consent for a thyroid or parathyroid surgery, they will be asked to participate in the study. Patients who are currently using narcotics would be excluded. We would then randomize participants to the "opt-in" protocol versus being provided with a standard opioid prescription after surgery. Patients in the opt-in protocol will be recommended a pain treatment regimen with over-the-counter medications, such as acetaminophen or ibuprofen. These patients will be reassured that if their pain is uncontrolled after discharge, a narcotic prescription will be called in to their pharmacy if requested.

We will assess patient pain scores and medication use in the recovery area using the electronic medical record. We will collect data on patient pain scores and medication use after discharge on a daily basis via phone call or electronically transmitted survey. We will also evaluate patients at the time of their follow-up visits. Any patient phone calls will be routed to study personnel who will fill narcotic prescription requests if requested. Finally, among patients who do receive an opioid prescription, we will track their opioid consumption.

详细描述

Due to the current opioid epidemic, there has been increased focus on the prescribing patterns of physicians and greater incentive to reduce the amount of narcotic pain medication prescribed.

A prospective study was recently published in Annals of Surgery by Ruffolo et al. which described an opt-in narcotic treatment program for 216 patients who underwent outpatient endocrine cervical surgery (1). Patients were counseled in the pre-operative visit that after the surgery, they would be provided the option of narcotic pain medication versus over-the-counter medication. Prior to discharge, patients were evaluated by a member of the surgical team and offered a choice of postoperative pain medications. The study found only 4% of patients requested narcotic pain medication and achieved a 96.6% reduction in postoperative narcotic use. No patients called in to request narcotic pain medication after discharge.

The study participants were compared to a retrospective cohort of patients who were given narcotic medication postoperatively as the default option. There have been no randomized controlled trials comparing the two pain medication strategies in outpatient cervical endocrine surgery. Additionally, in that study, the level of postoperative pain was not fully assessed and quality of life measures were not studied.

In our institutional practice, having a member of the surgical team visit the patient at the bedside to assess pain level is not part of the standard postoperative work flow, given that the operative team is usually operating at the time the patient is discharged. In order to assess the feasibility of implementing such a program within our practice, we plan to develop alternative methods of presenting the decision for postoperative pain treatment in the immediate postoperative period that fits into our standard practice.

Significance:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Care Provider)

盲法说明

Attending surgeons are not aware of participant treatment arm until after the participant undergoes their operation

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligibility for outpatient parathyroidectomy, thyroidectomy or neck dissection Patients aged 18 or older English-speaking: Our provided materials (video instruction, written instructions, survey material) will be in English and we want to ensure clear communication with our study subjects. Once we have demonstrated feasibility of such an opt-in policy with our English-speaking subjects, we will expand our materials to additional languages.

排除标准

  • Prior history of narcotic use Inpatient admission after surgery

结局指标

主要结局

oral morphine equivalents consumed

时间窗: Postoperative Day 0-7

Possible predictors for narcotic use or higher pain scores will be assessed, including age, sex, type of surgery and preoperative questionnaire (PHQ-9) score using a mixed-effects model.

Postoperative pain scores

时间窗: Postoperative Day 0-7

Pain scores will be compared using regression analysis and t-tests.

次要结局

  • Postoperative Day 0-7(Postoperative Day 7)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James Wu, MD

Dr. James Wu

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验